Drug Side Effects
Search
MYXOID LIPOSARCOMA
MYXOID LIPOSARCOMA
was reported 34 times
MYXOID LIPOSARCOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
alpha-Glucosidase Inhibitor [EPC]
1
0.0002
1
Bile Acid Sequestrant [EPC]
1
0.0001
2
Interleukin-17A Antagonist [EPC]
3
0.0001
3
Provitamin D2 Compound [EPC]
1
0.0000
4
BCL-2 Inhibitor [EPC]
2
0.0000
5
gamma-Aminobutyric Acid-ergic Agonist [EPC]
2
0.0000
6
Vascular Endothelial Growth Factor Inhibitor [EPC]
4
0.0000
7
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
8
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
9
Alkylating Drug [EPC]
4
0.0000
10
Azole Antifungal [EPC]
2
0.0000
11
Xanthine Oxidase Inhibitor [EPC]
2
0.0000
12
Anti-IgE [EPC]
1
0.0000
13
Dietary Cholesterol Absorption Inhibitor [EPC]
1
0.0000
14
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
15
Folate Analog Metabolic Inhibitor [EPC]
4
0.0000
16
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
17
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
18
Phosphodiesterase 4 Inhibitor [EPC]
1
0.0000
19
HMG-CoA Reductase Inhibitor [EPC]
2
0.0000
20
Interferon beta [EPC]
1
0.0000
21
Tumor Necrosis Factor Blocker [EPC]
4
0.0000
22
Vitamin D [EPC]
1
0.0000
23
Vitamin B12 [EPC]
1
0.0000
24
Vitamin C [EPC]
1
0.0000
25
Kinase Inhibitor [EPC]
1
0.0000
26
Benzodiazepine [EPC]
1
0.0000
27
Corticosteroid [EPC]
1
0.0000
28
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000